Koos Boeve
26 Chapter 1 REFERENCES 1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015 Mar;65(2):87-108. 2. Van Dijk BA, Gatta G, Capocaccia R, Pierannunzio D, Strojan P, Licitra L, et al. Rare cancers of the head and neck area in Europe. Eur J Cancer 2012 Apr;48(6):783- 796. 3. Hashibe M, Li Q, Chen CJ, Hsu WL, Lou PJ, Zhu C, et al. Involuntary smoking and the risk of head and neck cancer in an East Asian population. Cancer Epidemiol 2019 Apr;59:173-177. 4. Melchers LJ, Mastik MF, Samaniego Cameron B, van Dijk BA, de Bock GH, van der Laan BF, et al. Detection of HPV- associated oropharyngeal tumours in a 16-year cohort: more than meets the eye. Br J Cancer 2015 Apr 14;112(8):1349-1357. 5. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006 Oct;15(10):1765-1777. 6. Maruccia M, Onesti MG, Parisi P, Cigna E, Troccola A, Scuderi N. Lip cancer: a 10- year retrospective epidemiological study. Anticancer Res 2012 Apr;32(4):1543-1546. 7. Liu SY, Feng IJ, Wu YW, Chen CY, Hsiung CN, Chang HW, et al. Implication for second primary cancer from visible oral and oropharyngeal premalignant lesions in betel-nut chewing related oral cancer. Head Neck 2017 Jul;39(7):1428-1435. 8. Weatherspoon DJ, Chattopadhyay A, Boroumand S, Garcia I. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010. Cancer Epidemiol 2015 Aug;39(4):497-504. 9. Alrashdan MS, Cirillo N, McCullough M. Oral lichen planus: a literature review and update. Arch Dermatol Res 2016 Oct;308(8):539-551. 10. Chaturvedi AK, Anderson WF, Lortet- Tieulent J, Curado MP, Ferlay J, Franceschi S, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013 Dec 20;31(36):4550-4559. 11. Dutch cancer registration (IKNL), www. cijfersoverkanker.nl . Accessed June, 2019. 12. de Bree R, Takes RP, Shah JP, Hamoir M, Kowalski LP, Robbins KT, et al. Elective neck dissection in oral squamous cell carcinoma: Past, present and future. Oral Oncol 2019 Mar;90:87-93. 13. Hasegawa T, Tanakura M, Takeda D, Sakakibara A, Akashi M, Minamikawa T, et al. Risk factors associated with distant metastasis in patients with oral squamous cell carcinoma. Otolaryngol Head Neck Surg 2015 Jun;152(6):1053-1060. 14. Expert Panel on Radiation Oncology- Head and Neck, Salama JK, Saba N, Quon H, Garg MK, Lawson J, et al. ACR appropriateness criteria(R) adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol 2011 Jul;47(7):554-559. 15. Huang SH, O’Sullivan B. Oral cancer: Current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal 2013 Mar 1;18(2):e233-40. 16. Braakhuis BJ, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell carcinoma in the
Made with FlippingBook
RkJQdWJsaXNoZXIy ODAyMDc0